Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

The document concludes that understanding how adult stem and progenitor cells move is crucial for tissue repair and developing cell therapies.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

The technique allowed noninvasive tracking of hair stem cell survival and growth, showing potential for hair loss research.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.